Mech-Mind Siasun Robot&Automation (09615): Stabilization Period Ends, Over-allotment Option Lapses
Mech-Mind Siasun Robot&Automation (09615) announced that the stabilization period in respect of the global offering ended on Saturday, September 26, 2026 (being the 30th day after the last day for the submission of applications under the Hong Kong public offering).
Mech-Mind Siasun Robot&Automation (09615) announced that the stabilization period in respect of the global offering ended on Saturday, September 26, 2026 (being the 30th day after the last day for lodging applications under the Hong Kong public offering).
The stabilization actions taken by the stabilizing manager, its affiliates, or any person acting on its behalf during the stabilization period were as follows: an aggregate of 3,471,060 shares were over-allocated in the international offering, and an aggregate of 3,471,060 H shares were purchased in the market during the stabilization period at prices ranging from HK$76.10 to HK$101.70 per H share.
The sponsor and overall coordinator (for itself and on behalf of the international underwriters) did not exercise the over-allotment option during the stabilization period, and the over-allotment option lapsed on Saturday, September 26, 2026. Accordingly, the Company has not issued and will not issue any H shares pursuant to the over-allotment option.
Related Articles

Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved

Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list

FANGZHOU JIANKE (06086) Caina Technology Incentive Plan
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved

Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list

FANGZHOU JIANKE (06086) Caina Technology Incentive Plan






